Strategic Ventures Blog

In recent years, the healthcare landscape has experienced significant transformations, largely driven by technological advancements that empower patients to take a more active role in managing their health.

On Wednesday, October 1, 2024,  Dr. Patrick Calhoun, President and Chief Science Officer of Nanocrine, Inc., visited the laboratories of the National Cancer Institute (NCI),  and tested for the first time Nanocrine’s revolutionary plasmonic chip using living cells.

On Wednesday, October 1, 2024,  Dr. Patrick Calhoun, President and Chief Science Officer of Nanocrine, Inc., visited the laboratories of the National Cancer Institute (NCI),  and tested for the first time Nanocrine’s revolutionary plasmonic chip using living cells.